Sign Up Now Keep up to date with the latest blogs, books & events
Questions ? Call 248-851-1600 a 0 Items - $0.00

From Vaccines to Statins: A Reply to Fake News in JAMA Cardiology

An article (jamacardiology_navar_2019_vp_190009) in the June, 2019 edition of JAMA Cardiology was titled, “Fear-Based Medical Misinformation and Disease Prevention: From Vaccines to Statins. In this article, the author states “fake medical news” as the reason that patients are exhibiting hesitancy about utilizing statins and vaccines.   The author correctly...

Read More

More Expensive, Ineffective Cholesterol-Lowering Medications Now Being Touted

  On March 10, 2018 at the annual American College of Cardiology (ACC) meeting, an “on the scene” video  was released reporting the results of the new PCSK9 cholesterol-lowering medication Praluent. (1)  This new class of LDL-cholesterol lowering medications works differently than statins.  PCSK9 inhibiters block an enzyme naturally...

Read More

New Cholesterol Drugs Protect High Risk Heart Patients: MORE FAKE NEWS!

In an on-line article in The New York Times today (3.17.17), the headline states, “Cholesterol-Slashing Drug Can Protect High-Risk Heart Patients, Study Finds.” The article describes the first test of the new cholesterol-lowering medication—Repatha. Repatha is part of the PCSK9 inhibiter family that works by lowering LDL-cholesterol levels through...

Read More